GLP1R and type 2 diabetes mellitus: The glucagon-like peptide-1 receptor agonist (GLP-1RA) and dipeptidyl peptidase-IV (DPP-IV) inhibitor are very often used in subjects with type 2 diabetes mellitus (T2DM).